Dr Makarand Jawadekar, Pfizer

Director of Portfolio Management & Performance Group, part of Worldwide Portfolio & Project Management division within Pfizer Global R&D at New London, USA. Also involved in R&D benchmarking metrics for speed, quality & costs, with a goal to enhance Pharmaceutical R&D productivity and advise the R&D business on system solution approaches and best practices. Previously, he was responsible for the "Drug Delivery Technology Assessment" function, and managed strategic-level decisions on external alliances, collaborations, and partnerships as well as due diligence activities, in conjunction with licensing & development groups, including those with external providers of drug delivery system companies. His extensive previous experience includes formulations/drug delivery, R&D, clinical manufacturing operations and managing "Strategic Outsourcing" of drug product development activities.

Paul Titley, R5 Pharma

CEO of R5 Pharmaceuticals Ltd, Paul has more than 30 years of experience in the development of pharmaceuticals. Originally with Wellcome and GlaxoWellcome, he later went into the contract sector with Quintiles and then Encap (General Manager). He specializes in process development and validation and has lectured on these subjects since 1983. R5 Pharmaceuticals is a new contract pharmaceutical development company based at BioCity, Nottingham, UK. R5 has been set up by a team of individuals with many years experience in the science and management of the contract development and manufacture of clinical trial materials. R5 will develop and manufacture clinical materials including tablets, capsules and injectables from its new facilities.

Faiz Kermani, Pharmbiosys

Dr Faiz Kermani has several years experience in both academia and the pharmaceutical industry. He has worked in pharmaceutical R&D, pricing and reimbursement, marketing and medical communications. He holds a PhD in Immunopharmacology from St Thomas' Hospital, London and a First Class Honours degree in Pharmacology with Toxicology from King's College, London. He has written extensively on international healthcare issues, and is on the editorial board of a number of publications. In March 2006, he was a delegate on the UK Government's Trade and Investment Biotech Scoping Mission to China and was a speaker at the subsequent presentation.

Jim Miller, PharmSource

James C. Miller is the founder and president of PharmSource Information Services, Inc. A preeminent expert in bio/pharmaceutical outsourcing, Jim established and presides over the pharmaceutical outsourcing industry's principal information database, PharmSource.com. He is editor and publisher of the monthly online newsletter, Bio/Pharmaceutical Outsourcing Report, as well as editor and publisher of the PharmSource.com online database of bio/pharma contract service providers. Jim serves as an editorial advisory board member for Advanstar Communication's Pharmaceutical Technology and BioPharm magazines. In addition, he writes regular columns on outsourcing for numerous trade magazines. Jim formerly was vice president of sales and marketing at Circa Pharmaceuticals, Inc., a solid dose manufacturer, and before that was president of St. Anthony Publishing, a provider of database information services for the health care industry. He holds an M.B.A. degree from Stanford University.

Liselotte Larsson, PhD Senior Director, Business Development and Alliances

With more than 10 years of experience in business development within the biopharmaceutical arena, Liselotte Larsson joined Camurus as Senior Director of Business Development and Alliances in March 2008. Dr Larsson is involved in product development, out-licensing and alliance management for Camurus' drug delivery technology and proprietary products. Prior to joining Camurus, Dr Larsson was Senior Manager of Marketing and Sales and part of the management team in Novozymes Biopharma, focusing on out-sourcing of biological production. Dr Larsson received her MSc and PhD in Biotechnology at Lund University, Sweden, and has been working with project management, technology transfer, process development and GMP manufacturing of biological active ingredients.

Rolf Urban, Stada

Currently Director Production of Stada Pharmaceuticals with responsibility for internal customer service, supply chain management, purchasing, manufacturing, packaging and technical services. He is member of the senior management team and implemented a unique integrated supply chain model leading to world class performance. In his previous role, as Director Global Production, he led the development and implementation of Stada’s global technical operations strategy using FMCG as benchmark. Prior to joining Stada, Rolf held various management positions with Procter & Gamble in the US and Europe. He implemented innovative time-to-market systems for R&D and product supply and led the global rollout in the Pharmaceuticals business unit. He started his career as product supply and quality manager at Procter & Gamble’s German plant. Rolf has 13 years experience in Health Care and FMCG. Rolf holds an MBA degree from IMD (Institut of Management Development), Lausanne and a PhD in Pharmacology from Freiburg University. His educational background is an MS in Pharmacy.

Other judges include

Rolf Lambert, Consultant, Kemin Health
Nathalie Wardé, Consultant, Nad Pharma Consulting
Dr Kevin Robinson, Editorial Director, Pharma Magazine